# KCNC1

## Overview
The KCNC1 gene encodes the potassium voltage-gated channel subfamily C member 1 (Kv3.1), a critical component of the voltage-gated potassium channel family. This protein is integral to the rapid repolarization of action potentials in neurons, facilitating high-frequency firing and synaptic transmission. Kv3.1 channels are characterized by their large unit conductances, high activation thresholds, and rapid activation and deactivation kinetics, making them essential for maintaining neuronal excitability, particularly in fast-spiking GABAergic interneurons within the central nervous system (Poirier2017Loss; Muona2014A). The channel's structure includes six transmembrane segments, with distinct domains responsible for ion conduction and voltage sensing (Li2021Kv3.1). Mutations in KCNC1 have been implicated in various neurological disorders, underscoring its importance in neurophysiological processes and its potential as a target for therapeutic interventions (Cameron2019Encephalopathies; Muona2014A).

## Structure
The KCNC1 gene encodes the Kv3.1 channel, a voltage-gated potassium channel crucial for rapid repolarization in neurons. The protein structure includes six transmembrane segments (S1-S6), with the S5-S6 segments forming the ion-conducting pore domain and the S1-S4 segments constituting the voltage-sensing domain (VSD) (Li2021Kv3.1). The S4 segment, containing six positively charged residues, acts as the main voltage sensor (Muona2014A).

The Kv3.1 channel features a cytoplasmic tetramerization domain (T1) that facilitates interactions with the C-terminal axonal targeting motif (ATM) and is involved in gating control (Chi2022Cryo-EM). The T1 domain's α6 helices form a ring-like structure that interacts with the S4/S5 linker and S6T, stabilizing the open state of the channel (Chi2022Cryo-EM). The channel exhibits a domain-swapped architecture, with the VSD from one subunit close to the S5/S6 helices of an adjacent subunit (Chi2022Cryo-EM).

Kv3.1 exists in different splice variants, including Kv3.1a and Kv3.1b, which differ in their cytoplasmic COOH-terminal domain. Kv3.1b is enriched in axons due to interactions with ankyrin G, while Kv3.1a is retained in somatodendritic membranes (Chi2022Cryo-EM; Kaczmarek2017Kv3).

## Function
The KCNC1 gene encodes the K V 3.1 protein, a subunit of the K V 3 subfamily of voltage-gated potassium channels. These channels are crucial for the rapid repolarization of the action potential in neurons, characterized by large unit conductances, high activation thresholds, and very fast activation and deactivation kinetics (Poirier2017Loss). K V 3.1 channels are predominantly expressed in the central nervous system, especially in fast-spiking GABAergic interneurons, where they play a key role in maintaining high-frequency neuronal firing and regulating neuronal excitability (Cameron2019Encephalopathies; Muona2014A).

In healthy human cells, K V 3.1 channels contribute to the proper functioning of neurons by facilitating fast channel activation and membrane repolarization, which is essential for high-frequency firing and synaptic transmission (Park2019KCNC1‐related). These channels are involved in setting the membrane resting potential, modifying action potential duration, and regulating neurotransmitter release, thereby influencing processes such as cognition and motor control (Cameron2019Encephalopathies). The proper function of K V 3.1 is crucial for maintaining the firing properties of fast-spiking neurons, impacting neurotransmitter release and preventing cell death (Muona2014A).

## Clinical Significance
Mutations in the KCNC1 gene, which encodes the Kv3.1 subunit of voltage-gated potassium channels, are associated with several neurological disorders. A well-documented mutation, c.959G>A (p.Arg320His), is linked to progressive myoclonus epilepsy (PME) and myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK). This mutation results in a dominant-negative loss-of-function effect, significantly reducing potassium currents and impairing high-frequency neuronal firing, which is crucial for normal neuronal function (Oliver2017Myoclonus; Carpenter2021Progressive; Muona2014A).

The p.Arg320His mutation is associated with symptoms such as action myoclonus, tonic-clonic seizures, and ataxia, with onset typically occurring between ages 3 and 15. Patients often experience severe motor disabilities, although cognitive function is generally preserved (Oliver2017Myoclonus; Muona2014A). 

Other KCNC1 variants, such as p.Ala421Val, are linked to developmental and epileptic encephalopathy (DEE) and developmental encephalopathy without seizures. These variants also exhibit a loss-of-function effect, leading to reduced neuronal excitability and developmental delays (Park2019KCNC1‐related; Cameron2019Encephalopathies). The phenotypic spectrum of KCNC1-related disorders is broad, highlighting the gene's significant role in various neuropsychiatric conditions (Cameron2019Encephalopathies).

## Interactions
The KCNC1 gene encodes the Kv3.1 channel, a member of the voltage-gated potassium channel family, which plays a crucial role in neuronal excitability and synaptic transmission. While specific interactions of the KCNC1 protein with other proteins or nucleic acids are not extensively detailed in the provided context, some insights can be drawn from related studies.

The Kv3.1 channel, encoded by KCNC1, is known to form homomers or heteromers with other Kv3 subunits, creating tetrameric potassium ion channels that are essential for high-frequency neuronal firing (Cameron2019Encephalopathies; Muona2014A). This ability to form heterotetramers suggests potential interactions with other Kv3 subunits, although specific partners are not identified in the context.

In the cerebellum, the protein PRRT1 has been shown to preferentially interact with potassium channel proteins KCNC3/1, indicating a possible interaction network involving KCNC1 in this brain region (Chen2014Interaction). This interaction may influence the localization and function of the Kv3.1 channel, contributing to its role in synaptic transmission.

Overall, while direct interactions of KCNC1 with other proteins or nucleic acids are not explicitly detailed, its role in forming channel complexes and potential interactions with auxiliary proteins like PRRT1 highlight its involvement in complex neuronal signaling pathways.


## References


[1. (Carpenter2021Progressive) Jenna C. Carpenter, Roope Männikkö, Catherine Heffner, Jana Heneine, Marisol Sampedro‐Castañeda, Gabriele Lignani, and Stephanie Schorge. Progressive myoclonus epilepsykcnc1variant causes a developmental dendritopathy. Epilepsia, 62(5):1256–1267, March 2021. URL: http://dx.doi.org/10.1111/epi.16867, doi:10.1111/epi.16867. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/epi.16867)

[2. (Poirier2017Loss) Karine Poirier, Géraldine Viot, Laura Lombardi, Clémence Jauny, Pierre Billuart, and Thierry Bienvenu. Loss of function of kcnc1 is associated with intellectual disability without seizures. European Journal of Human Genetics, 25(5):560–564, February 2017. URL: http://dx.doi.org/10.1038/ejhg.2017.3, doi:10.1038/ejhg.2017.3. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2017.3)

[3. (Muona2014A) Mikko Muona, Samuel F Berkovic, Leanne M Dibbens, Karen L Oliver, Snezana Maljevic, Marta A Bayly, Tarja Joensuu, Laura Canafoglia, Silvana Franceschetti, Roberto Michelucci, Salla Markkinen, Sarah E Heron, Michael S Hildebrand, Eva Andermann, Frederick Andermann, Antonio Gambardella, Paolo Tinuper, Laura Licchetta, Ingrid E Scheffer, Chiara Criscuolo, Alessandro Filla, Edoardo Ferlazzo, Jamil Ahmad, Adeel Ahmad, Betul Baykan, Edith Said, Meral Topcu, Patrizia Riguzzi, Mary D King, Cigdem Ozkara, Danielle M Andrade, Bernt A Engelsen, Arielle Crespel, Matthias Lindenau, Ebba Lohmann, Veronica Saletti, João Massano, Michael Privitera, Alberto J Espay, Birgit Kauffmann, Michael Duchowny, Rikke S Møller, Rachel Straussberg, Zaid Afawi, Bruria Ben-Zeev, Kaitlin E Samocha, Mark J Daly, Steven Petrou, Holger Lerche, Aarno Palotie, and Anna-Elina Lehesjoki. A recurrent de novo mutation in kcnc1 causes progressive myoclonus epilepsy. Nature Genetics, 47(1):39–46, November 2014. URL: http://dx.doi.org/10.1038/ng.3144, doi:10.1038/ng.3144. This article has 242 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.3144)

[4. (Li2021Kv3.1) Xiaoyang Li, Yongsheng Zheng, Shaoyuan Li, Umesh Nair, Chong Sun, Chongbo Zhao, Jiahong Lu, Victor Wei Zhang, Snezana Maljevic, Steven Petrou, and Jie Lin. Kv3.1 channelopathy: a novel loss-of-function variant and the mechanistic basis of its clinical phenotypes. Annals of Translational Medicine, 9(18):1397–1397, September 2021. URL: http://dx.doi.org/10.21037/atm-21-1885, doi:10.21037/atm-21-1885. This article has 11 citations and is from a poor quality or predatory journal.](https://doi.org/10.21037/atm-21-1885)

[5. (Chi2022Cryo-EM) Gamma Chi, Qiansheng Liang, Akshay Sridhar, John B. Cowgill, Kasim Sader, Mazdak Radjainia, Pu Qian, Pablo Castro-Hartmann, Shayla Venkaya, Nanki Kaur Singh, Gavin McKinley, Alejandra Fernandez-Cid, Shubhashish M. M. Mukhopadhyay, Nicola A. Burgess-Brown, Lucie Delemotte, Manuel Covarrubias, and Katharina L. Dürr. Cryo-em structure of the human kv3.1 channel reveals gating control by the cytoplasmic t1 domain. Nature Communications, July 2022. URL: http://dx.doi.org/10.1038/s41467-022-29594-w, doi:10.1038/s41467-022-29594-w. This article has 15 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-29594-w)

[6. (Cameron2019Encephalopathies) Jillian M. Cameron, Snezana Maljevic, Umesh Nair, Ye Htet Aung, Benjamin Cogné, Stéphane Bézieau, Edward Blair, Bertrand Isidor, Christiane Zweier, André Reis, Mary Kay Koenig, Timothy Maarup, Dean Sarco, Alexandra Afenjar, A. H. M. Mahbubul Huq, Mary Kukolich, Thierry Billette de Villemeur, Caroline Nava, Bénédicte Héron, Steven Petrou, and Samuel F. Berkovic. Encephalopathies with kcnc1 variants: genotype‐phenotype‐functional correlations. Annals of Clinical and Translational Neurology, 6(7):1263–1272, July 2019. URL: http://dx.doi.org/10.1002/acn3.50822, doi:10.1002/acn3.50822. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.50822)

[7. (Kaczmarek2017Kv3) Leonard K. Kaczmarek and Yalan Zhang. Kv3 channels: enablers of rapid firing, neurotransmitter release, and neuronal endurance. Physiological Reviews, 97(4):1431–1468, October 2017. URL: http://dx.doi.org/10.1152/physrev.00002.2017, doi:10.1152/physrev.00002.2017. This article has 153 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1152/physrev.00002.2017)

[8. (Park2019KCNC1‐related) Joohyun Park, Mahmoud Koko, Ulrike B. S. Hedrich, Andreas Hermann, Kirsten Cremer, Edda Haberlandt, Mona Grimmel, Bader Alhaddad, Stefanie Beck‐Woedl, Merle Harrer, Daniela Karall, Lisa Kingelhoefer, Andreas Tzschach, Lars C. Matthies, Tim M. Strom, Erich Bernd Ringelstein, Marc Sturm, Hartmut Engels, Markus Wolff, Holger Lerche, and Tobias B. Haack. Kcnc1‐related disorders: new de novo variants expand the phenotypic spectrum. Annals of Clinical and Translational Neurology, 6(7):1319–1326, June 2019. URL: http://dx.doi.org/10.1002/acn3.50799, doi:10.1002/acn3.50799. This article has 44 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.50799)

[9. (Oliver2017Myoclonus) Karen L. Oliver, Silvana Franceschetti, Carol J. Milligan, Mikko Muona, Simone A. Mandelstam, Laura Canafoglia, Anna M. Boguszewska‐Chachulska, Amos D. Korczyn, Francesca Bisulli, Carlo Di Bonaventura, Francesca Ragona, Roberto Michelucci, Bruria Ben‐Zeev, Rachel Straussberg, Ferruccio Panzica, João Massano, Daniel Friedman, Arielle Crespel, Bernt A. Engelsen, Frederick Andermann, Eva Andermann, Krystyna Spodar, Anetta Lasek‐Bal, Patrizia Riguzzi, Elena Pasini, Paolo Tinuper, Laura Licchetta, Elena Gardella, Matthias Lindenau, Annette Wulf, Rikke S. Møller, Felix Benninger, Zaid Afawi, Guido Rubboli, Christopher A. Reid, Snezana Maljevic, Holger Lerche, Anna‐Elina Lehesjoki, Steven Petrou, and Samuel F. Berkovic. Myoclonus epilepsy and ataxia due to <scp>kcnc</scp>1 mutation: analysis of 20 cases and <scp>k</scp>+ channel properties. Annals of Neurology, 81(5):677–689, May 2017. URL: http://dx.doi.org/10.1002/ana.24929, doi:10.1002/ana.24929. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.24929)

[10. (Chen2014Interaction) Ning Chen, Nikhil J. Pandya, Frank Koopmans, Violeta Castelo-Székelv, Roel C. van der Schors, August B. Smit, and Ka Wan Li. Interaction proteomics reveals brain region-specific ampa receptor complexes. Journal of Proteome Research, 13(12):5695–5706, November 2014. URL: http://dx.doi.org/10.1021/pr500697b, doi:10.1021/pr500697b. This article has 50 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/pr500697b)